Lates News

CVS Health Corporation's stock surged over 6% in pre-market trading. Earlier, the company raised its adjusted earnings per share guidance for the 2024 fiscal year to $6.30-6.40, up from the previous expectation of $6.00-6.20. The market had estimated $6.13.